Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-05-2023 | Conjunctivitis | Case report

Dupilumab/prednisolone

Various toxicities: 4 case reports

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference McKenzie PL, et al. Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events. Pediatric Dermatology 38: 1178-1184, No. 5, 13 Sep 2021. Available from: URL: http://doi.org/10.1111/pde.14799 McKenzie PL, et al. Experience using dupilumab for pediatric atopic dermatitis at a tertiary care c enter: Inadequate response and adverse events. Pediatric Dermatology 38: 1178-1184, No. 5, 13 Sep 2021. Available from: URL: http://​doi.​org/​10.​1111/​pde.​14799
Metadata
Title
Dupilumab/prednisolone
Various toxicities: 4 case reports
Publication date
01-05-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-38407-7

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Nivolumab

Case report

Infliximab

Case report

Antineoplastics

Case report

Multiple drugs